Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,336,000
-14,000 (-1.04%)
At close: Jun 5, 2026

Samsung Biologics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
520,363148,851391,222367,937890,82047,410
Short-Term Investments
1,132,5911,336,232940,0671,688,3382,204,212473,985
Trading Asset Securities
----98,506850,040
Cash & Short-Term Investments
1,652,9541,485,0831,331,2892,056,2763,193,5371,371,435
Cash Growth
28.61%11.55%-35.26%-35.61%132.86%60.96%
Accounts Receivable
555,157654,728-0--0
Other Receivables
11,26821,739----
Receivables
566,425676,467-0--0
Inventory
2,291,5562,128,1642,818,2762,641,3682,375,8191,012,871
Prepaid Expenses
23,49114,34928,25126,83023,2018,579
Other Current Assets
126,324104,3041,340,302797,513865,099430,291
Total Current Assets
4,660,7504,408,3675,518,1185,521,9886,457,6572,823,175
Property, Plant & Equipment
6,748,3106,037,5325,837,4824,342,4243,871,4522,227,687
Long-Term Investments
73,72578,32559,60547,43538,1102,661,499
Goodwill
--1,677,6081,677,6081,677,608-
Other Intangible Assets
75,67260,1931,294,7051,580,4231,541,85032,172
Long-Term Accounts Receivable
--00-00
Long-Term Deferred Tax Assets
143,229132,837165.09---
Long-Term Deferred Charges
--2,592,9902,574,0572,741,848-
Other Long-Term Assets
293,282343,458355,592302,236253,524225,477
Total Assets
11,995,00011,060,74217,336,29616,046,19716,582,0507,970,011
Accounts Payable
213,61959,814177,992201,70959,61632,251
Accrued Expenses
260,442314,573545,403281,317207,43774,322
Short-Term Debt
--327,000654,500582,78350,000
Current Portion of Long-Term Debt
319,798319,713-733,405556,017109,855
Current Portion of Leases
26,7557,258138,594144,031142,2477,537
Current Income Taxes Payable
380,499355,700375,388191,212223,299110,174
Current Unearned Revenue
--400,007399,818432,680-
Other Current Liabilities
1,538,9001,475,8601,888,8041,551,8701,977,462723,156
Total Current Liabilities
2,740,0142,532,9173,853,1884,157,8614,181,5421,107,295
Long-Term Debt
599,101599,0121,012,757239,783965,0901,114,684
Long-Term Leases
248,8341,1127,889137,614267,89610,671
Pension & Post-Retirement Benefits
--5,5475,117--
Long-Term Deferred Tax Liabilities
30,790-972,0621,184,4201,214,216487,712
Other Long-Term Liabilities
453,425476,590580,177490,910968,833258,547
Total Liabilities
4,072,1643,609,6316,431,6206,215,7057,597,5762,978,909
Common Stock
115,727115,727177,935177,935177,935165,413
Additional Paid-In Capital
3,391,9263,391,9265,663,1115,663,1115,663,1112,487,313
Retained Earnings
7,340,2066,870,9615,086,6094,003,2933,145,6012,347,187
Treasury Stock
-2,907,695-2,907,695----
Comprehensive Income & Other
-17,329-19,809-22,979-13,847-2,173-8,811
Shareholders' Equity
7,922,8367,451,11110,904,6769,830,4928,984,4744,991,102
Total Liabilities & Equity
11,995,00011,060,74217,336,29616,046,19716,582,0507,970,011
Total Debt
1,194,488927,0941,486,2391,909,3332,514,0331,292,747
Net Cash (Debt)
458,466557,989-154,951146,943679,50478,688
Net Cash Growth
----78.38%763.54%17.19%
Net Cash Per Share
7543.658326.90-2177.123174.3414965.871828.54
Filing Date Shares Outstanding
46.2946.2446.2946.2946.2943.03
Total Common Shares Outstanding
46.2946.2446.2946.2946.2943.03
Working Capital
1,920,7361,875,4491,664,9291,364,1272,276,1151,715,881
Book Value Per Share
171153.01161141.62235568.21212363.16194087.06115982.76
Tangible Book Value
7,847,1647,390,9177,932,3636,572,4615,765,0164,958,931
Tangible Book Value Per Share
169518.32159839.84171358.83141981.56124538.73115235.15
Land
742,348461,974141,114141,065141,065-
Buildings
3,378,8003,337,8951,956,9581,943,6941,376,222832,519
Machinery
3,502,7673,262,1772,629,5982,525,3441,811,9821,380,919
Construction In Progress
285,748430,1611,833,097202,411825,199583,360